duloxetine capsule, delayed release
cadila healthcare limited - duloxetine hydrochloride (unii: 9044sc542w) (duloxetine - unii:o5tnm5n07u) - duloxetine 20 mg - duloxetine delayed-release capsules, usp are indicated for the treatment of major depressive disorder (mdd). the efficacy of duloxetine was established in four short term and one maintenance trial in adults [see clinical studies (14.1) ]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least 5 of the following 9 symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, or a suicide attempt or suicidal ideation. duloxetine delayed-release capsules, usp are indicated for the treatment of generalized anxiety disorder (gad). the efficacy of duloxetine was established in three short-term trials and one maintenance trial in adults [see clini
glyburide tablet
cadila pharmaceuticals limited - glyburide (unii: sx6k58tvwc) (glyburide - unii:sx6k58tvwc) - glyburide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glyburide tablets are contraindicated in patients with: 1. known hypersensitivity or allergy to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin. 3. type i diabetes mellitus. 4. concomitant administration of bosentan.
aripiprazole tablet, orally disintegrating
cadila healthcare limited - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole orally disintegrating tablets are indicated for the treatment of: - schizophrenia [see clinical studies (14.1)] additional pediatric use information is approved for otsuka america pharmaceutical, inc.'s abilify® (aripiprazole) product. however, due to otsuka america pharmaceutical, inc.'s marketing exclusivity rights, this drug product is not labeled with that information. aripiprazole is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including aripiprazole, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-researchprograms/pregnancyregistry/. risk
labetalol hydrochloride tablet, film coated
cadila pharmaceuticals limited - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride tablets, are indicated in the management of hypertension. labetalol hydrochloride tablets may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. labetalol hydrochloride is contraindicated in bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product (see warnings). beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.
cadigrel tablets film-coated
cadila pharmaceuticals ltd. - clopidogrel (clopidogrel bisulfate) - tablets film-coated - 75mg
nebidon 5 tablets
cadila pharmaceuticals ltd. plot no. 1389 trasad road - nebivolol (nebivolol hydrochloride) - tablets - 5mg
pzycadila-a t i inj v inj
pharmacia - coagulation factor lx - v inj - 600iu.(plasma protein human+nacl,sod.cit.) - inj
cadiprim
cadila pharmaceuticals ltd - sulfamethoxazole; trimethoprim - tablet; oral - 400mg; 80mg
cefamor
cadila pharmaceuticals limited - cefalexin monohydrate - syrup; oral - 125mg/5ml
cephalexin
cadila pharmaceuticals limited - cefalexin monohydrate - capsule; oral - 500mg